Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Juli 2011 15:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2011

CAMBRIDGE, Mass., July 25, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
21. Juni 2011 10:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals CEO Craig Wheeler Named Ernst & Young Entrepreneur Of The Year(R) 2011 New England Award Winner

CAMBRIDGE, Mass., June 21, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
20. Juni 2011 15:15 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Study Showing M402 Inhibits Tumor Metastasis in Multiple Murine Oncology Models Published in PLoS One

CAMBRIDGE, Mass., June 20, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs,...
27. Mai 2011 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences

CAMBRIDGE, Mass., May 27, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
25. Mai 2011 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date for 2011 Annual Meeting of Stockholders

CAMBRIDGE, Mass., May 25, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
12. Mai 2011 11:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Appoints Nic G. Scalfarotto, D.V.M., Vice President of Regulatory Affairs

CAMBRIDGE, Mass., May 12, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced...
05. Mai 2011 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2011

CAMBRIDGE, Mass., May 5, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
28. April 2011 10:15 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Webcast Presentations at Two Upcoming Investment Conferences

CAMBRIDGE, Mass., April 28, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
25. April 2011 14:15 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2011 Financial Results

CAMBRIDGE, Mass., April 25, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
01. März 2011 09:20 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference

CAMBRIDGE, Mass., March 1, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...

Vorherige Seite

Nächste Seite